Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[d-Ala2]YFa-on antinociception and opioid receptor regulation

European Journal of Pain

Volumn 14, Issue 3, 2010, Pages 295.e1-295.e9

  Vats, Ishwar Dutt ^a,b   Snehlata, ^a   Nath, Mahendra ^b   Pasha, M A Qadar ^a   Pasha, Santosh ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Antinociception; Chimeric opioid peptides; Opioid receptor expression; Tolerance; YFa

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; METENKEPHALIN[6 ARGININE 7 PHENYLALANINE]; MU OPIATE RECEPTOR; NALOXONAZINE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME REGULATION; MALE; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIL FLICK TEST; TREATMENT DURATION; WESTERN BLOTTING;

EID: 77049118748     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.05.014     Document Type: Article

References (58)

1. Akiyama K., Gee K.W., Mosberg H.I., Hruby V.J., and Yamamura H.I. Characterization of [3H][2-D-penicillamine 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG 108-15). Proc Natl Acad Sci USA 82 (1985) 2543-2547
2. Allard M., Geoffre S., Legendre P., Vincent J.D., and Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 500 (1989) 169-176
3. Amiche M., Sagan S., Mor A., Delfour A., and Nicolas P. Dermenkephalin (Tyr-d-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor. Mol Pharmacol 35 (1989) 774-779
4. Benyhe S., Farkas J., Toth G., and Wollemann M. Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain. J Neurosci Res 48 (1997) 249-258
5. Beyer A., Hollunder J., Nasheuer H.P., and Wilhelm T. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol Cell Proteomics 3 (2004) 1083-1092
6. Bhargava H.N., and Gulati A. Downregulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 190 (1990) 305-311
7. Bhargava H.N., Matwyshyn G.A., Reddy P.L., and Veeranna. Effects of naltrexone on the binding of [3H]d-Ala2, Met-Phe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat. Gen Pharmacol 24 (1993) 1351-1357
8. Bhargava H.N., Cao Y.J., and Zhao G.M. Effect of 7-nitroindazole on tolerance to morphine, U-50, 488H and d-Pen2, d-Pen5] enkephalin in mice. Peptides 18 (1997) 797-800
9. Bi J., Hu X., Loh H.H., and Wei L.N. Mouse kappa-opioid receptor mRNA differential transport in neurons. Mol Pharmacol 64 (2003) 594-599
10. Broccardo M., and Improta G. Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural delta opioid receptor agonist [d-Ala2]deltorphin II in the rat. Eur J Pharmacol 218 (1992) 69-73
11. Burford N.T., Tolbert L.M., and Sadee W. Specific G protein activation and mu-opioid receptor internalization caused by morphine, DAMGO and endomorphin I. Eur J Pharmacol 342 (1998) 123-126
12. Buzas B., and Cox B.M. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 76 (1997) 479-489
13. Buzas B., Rosenberger J., and Cox B.M. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 7 (1996) 1505-1508
14. Chaturvedi K. Opioid peptides, opioid receptors and mechanism of down regulation. Indian J Exp Biol 41 (2003) 5-13
15. Cheng P.Y., Wu D., Decena J., Soong Y., McCabe S., and Szeto H.H. Opioid-induced stimulation of fetal respiratory activity by [d-Ala2]deltorphin I. Eur J Pharmacol 230 (1993) 85-88
16. Clarke S., Zimmer A., Zimmer A.M., Hill R.G., and Kitchen I. Region selective upregulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience 122 (2003) 479-489
17. Darula Z., Kover K.E., Monory K., Borsodi A., Mako E., Ronai A., et al. Deltorphin II analogues with 6-hydroxy-2-aminotetralin-2-carboxylic acid in position 1. J Med Chem 43 (2000) 1359-1366
18. David M., Moisand C., Meunier J.C., Morgat J.L., Gacel G., and Roques B.P. [3H]Tyr-d-Ser-Gly-Phe-Leu-Thr: a specific probe for the delta-opiate receptor subtype in brain membranes. Eur J Pharmacol 78 (1982) 385-387
19. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., et al. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci USA 86 (1989) 5188-5192
20. Ferguson Stephen.S.G. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53 (2001) 1-24
21. Galina H.Z., and Kastin A.J. Existence of antiopiate system as illustrated by MIF-1/Tyr-MIF-1. Life Sci 39 (1986) 2153-2159
22. Goodman C.B., Elmer G.I., Yang H.-Y.T., Lee C.H., and Rothman R.B. Modulation of opioid receptors by antiopioid peptides. In: Tseng L.F. (Ed). The pharmacology of opioid peptides (1995), Harwood Academic Publishers, gmbh, Singapore 303-319
23. Goodman C.B., Emilien B., Becketts K., Cadet J.L., and Rothman R.B. Downregulation of m-opioid binding sites following chronic administration of NPFF and morphine. Peptides 17 (1996) 389-397
24. Gouarderes C., Sutak M., Zajac J.-M., and Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 237 (1993) 73-81
25. Greenbaum D., Colangelo C., Williams K., and Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4 (2003) 1171-1178
26. Greenberg M.J., Painter S.D., Dobble K.E., Naggle G.T., Price D.A., and Lehman H.K. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins. Fed Proc 42 (1983) 82-86
27. Gupta S., Pasha S., Gupta Y.K., and Bhardwaj D.K. Chimeric peptide of met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception. Peptides 20 (1999) 471-478
28. 2]YFa- on antinociception and its modulation in mice. Brain Res Bull 55 (2001) 51-57
29. Horner K.A., and Zadina J.E. Internalization and downregulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res 1028 (2004) 121-132
30. Inturrisi C.E., Umans J.G., Wolff D., Stern A.S., Lewis R.V., Stein S., et al. Analgesic activity of the naturally occurring heptapeptide met5enkephalin-Arg6-Phe7. Proc Natl Acad Sci USA 81 (1980) 5512-5514
31. Jiang Q., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I., et al. Differential antagonism of opioid delta antinociception by [d-Ala2,Leu5,Cys6]enkephalin and naltrindole 50-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 257 (1991) 1069-1075
32. 7, an endogenous opioid peptide, in cerebral cortex of human and rat. Life Sci 67 (2000) 61-71
33. Law P.Y., Louie A.K., and Loh H.H. Effect of pertussis toxin treatment on the downregulation of opiate receptors in neuroblastoma X glioma NG108-15 hybrid cells. J Biol Chem 260 (1985) 14818-14823
34. Law P.Y., Loh H.H., and Wei L.N. Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence. Neuropharmacology 47 (2004) 300-311
35. Lee S.C., and Yoburn B.C. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity. Pharmacol Biochem Behav 66 (2000) 347-351
36. Liu-Chen L.Y. Agonist-induced regulation and trafficking of kappa opioid receptors. Life Sci 75 (2004) 511-536
37. Malin D.H., Lake J.R., Fowler D.E., Hammond M.V., Brown S.L., Levya J.E., et al. FMRF-NH2 like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11 (1990) 277-280
38. Malin D.H., Lake J.R., Hammond M.V., Fowler D.E., Rogillio R.B., Brown S.L., et al. FMRF-NH2 like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 11 (1990) 969-972
39. Mcconalogue K., Grady E.F., Minnis J., Balestra B., Tonini M., Brecha N.C., et al. Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2. Neuroscience 90 (1999) 1051-1059
40. Nie L., Wu G., and Zhang W. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics 174 (2006) 2229-2243
41. Pol O., Palacio R.J., and Puig M.M. The expression of δ- and κ-opioid receptor is enhanced during intestinal Inflammation in mice. JPET 306 (2003) 455-462
42. Puehler W., Rittnera H.L., Mousa S.A., Brack A., Krause H., Steina C., et al. Interleukin-1 beta contributes to the upregulation of Kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation. Neuroscience 141 (2006) 989-998
43. Raffa R.B., and Jacoby H.I. Effect of [d-Met2]FMRFamide and other FMRFamide related peptides on mouse colonic propulsive motility: a structure-activity relationship study. J Pharmacol Exp Ther 254 (1990) 809-814
44. Raffa R.B., Kim A., Rice K.C., De Costa B.R., Codd E.E., and Rothman R.B. Low affinity of FMRFa and four FaRPs(FMRFamide related peptides), including the mammalian-derived FaRPs F8Fa(NPFF) and A18Fa, for opioid μ, δ, κ1, κ2a or κ2b receptors. Peptides 15 (1994) 401-404
45. Rossier J., Audigier Y., Ling N., Cros J., and Udenfriend S. Metenkephalin-Arg6-Phe7, present in high amounts in brain of rat, cattle and man, is an opioid agonist. Nature 288 (1980) 88-90
46. 2-like immunoreactivity. Proc Natl Acad Sci USA 81 (1984) 5002-5005
47. Trafton J.A., and Basbaum A.I. [d-Ala2,N-MePhe4,Gly-ol5]enkephalin-induced internalization of the micro opioid receptor in the spinal cord of morphine tolerant rats. Neuroscience 125 (2004) 541-543
48. Vats I.D., Dolt K.S., Kumar K., Karar J., Nath M., and Pasha S. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment. J Neurosci Res 86 (2008) 1599-1607
49. Wang Y., Li J.G., Huang P., Xu W., and Liu-Chen L.Y. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and downregulation. J Pharmacol Exp Ther 307 (2003) 1127-1134
50. Wei L.N., and Loh H.H. Regulation of opioid receptor expression. Curr Opin Pharmacol 2 (2002) 69-75
51. Wei L.N., Hu X., Bi J., and Loh H. Post-transcriptional regulation of mouse kappa-opioid receptor expression. Mol Pharmacol 57 (2000) 401-408
52. Wei L.N., Law P.Y., and Loh H.H. Post-transcriptional regulation of opioid receptors in the nervous system. Front Biosci 9 (2004) 1665-1679
53. Yang H.-Y.T., Fratta W., Majane E.A., and Costa E. Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1982) 7757-7761
54. Yang H.-Y.T., Panula P., Tang J., and Costa E. Characterisation and localization of met5-enkephalin-Arg6-Phe7 stored in various rat brain regions. J Neurochem 40 (1983) 969-976
55. Yoburn B.C., Billings B., and Duttaroy A. Opioid receptor regulation in mice. J Pharmacol Exp Ther 265 (1993) 314-320
56. Zadina J.E., Kastin A.J., Harrison L.M., Ge L.J., and Chang S.L. Opiate receptor changes after chronic exposure to agonists and antagonists. Ann N Y Acad Sci 757 (1995) 353-361
57. Zhang F., Li J., Li J.G., and Liu-Chen L.Y. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneace tamide] induces internalization and downregulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation. J Pharmacol Exp Ther 302 (2002) 1184-1192
58. Zhu J., Luo L.Y., Mao G.F., Ashby B., and Liu-Chen L.Y. Agonist induced desensitization and downregulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther 285 (1998) 28-36